David Onions was recently promoted from the role of chief scientific officer of Invitrogen unit BioReliance to chief medical officer of Invitrogen. The position is a new one at Invitrogen and a seemingly unusual role for someone at a firm focused on developing and selling molecular biology tools. This week, Onions spoke with BioCommerce Week about his new position and Invitrogen's strategy for more collaborative efforts in medical research that are closer to the patient.

Why does Invitrogen need a chief medical officer?

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.